CYTOSORBENTS CORP (CTSO) Stock Earnings & Estimates
NASDAQ:CTSO - US23283X2062 - Common Stock
0.9434 USD
+0.01 (+0.84%)
0.9564 USD
+0.01 (+1.38%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 34.69M -19.64% | 31.085M -10.39% | 35.595M 14.51% | 39.84M 11.93% | 48.296M 21.22% | 62.833M 30.10% | 88.559M 40.94% | 133.04M 50.23% | 277.47M 108.56% | 343.33M 23.74% | 452.77M 31.88% | |
| EBITDA YoY % growth | -30.64M -39.21% | -29.831M 2.64% | -14.708M 50.69% | -12.271M 16.57% | -3.363M 72.59% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -31.52M -38.61% | -31.293M 0.72% | -16.452M 47.43% | -11.312M 31.24% | -8.751M 22.64% | 1.347M 115.39% | 21.907M 1,526.35% | 56.166M 156.38% | 173.27M 208.50% | 222.68M 28.52% | 304.71M 36.84% | |
| Operating Margin | -90.86% | -100.67% | -46.22% | -28.39% | -18.12% | 2.14% | 24.74% | 42.22% | 62.45% | 64.86% | 67.30% | |
| EPS YoY % growth | -0.76 -33.33% | -0.65 14.47% | -0.38 41.54% | -0.13 65.11% | -0.09 33.33% | 0.04 140.38% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.05 -19.01% | -0.05 66.00% | -0.05 -155.00% | -0.05 -270.00% | -0.04 14.29% | -0.07 -49.99% |
| Revenue Q2Q % growth | 10.234M 8.98% | 11.05M 20.77% | 10.812M 23.89% | 11.322M 17.73% | 12.24M 19.60% | 12.75M 15.38% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -2.513M 42.00% | -2.734M 32.07% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.03 137.50% | -0.05 | 0.08 | 158.82% |
| Q1 2025 Q2Q % growth | -0.02 83.33% | -0.07 | 0.05 | 71.99% |
| Q4 2024 Q2Q % growth | -0.14 -7.69% | -0.06 | -0.08 | -116.73% |
| Q3 2024 Q2Q % growth | -0.04 80.95% | -0.06 | 0.02 | 38.08% |
| Q2 2024 Q2Q % growth | -0.08 42.86% | -0.10 | 0.02 | 19.56% |
| Q1 2024 Q2Q % growth | -0.12 29.41% | -0.12 | 0.00 | 1.96% |
| Q4 2023 Q2Q % growth | -0.13 -550.00% | -0.14 | 0.01 | 7.31% |
| Q3 2023 Q2Q % growth | -0.21 25.00% | -0.14 | -0.07 | -49.19% |
| Q2 2023 Q2Q % growth | -0.14 44.00% | -0.11 | -0.03 | -22.00% |
| Q1 2023 Q2Q % growth | -0.17 19.05% | -0.13 | -0.04 | -31.58% |
| Q4 2022 Q2Q % growth | -0.02 90.48% | -0.17 | 0.15 | 88.33% |
| Q3 2022 Q2Q % growth | -0.28 -86.67% | -0.17 | -0.11 | -67.38% |
| Q2 2022 Q2Q % growth | -0.25 -127.27% | -0.14 | -0.11 | -83.25% |
| Q1 2022 Q2Q % growth | -0.21 -110.00% | -0.12 | -0.09 | -68.07% |
| Q4 2021 Q2Q % growth | -0.21 | -0.14 | -0.07 | -55.50% |
| Q3 2021 Q2Q % growth | -0.15 -650.00% | -0.12 | -0.03 | -20.87% |
| Q2 2021 Q2Q % growth | -0.11 -37.50% | -0.04 | -0.07 | -175.53% |
| Q1 2021 Q2Q % growth | -0.10 | -0.03 | -0.07 | -194.15% |
| Q4 2020 Q2Q % growth | 0.00 100.00% | -0.04 | 0.04 | 100.00% |
| Q3 2020 Q2Q % growth | -0.02 90.48% | -0.09 | 0.07 | 78.33% |
| Q2 2020 Q2Q % growth | -0.08 27.27% | -0.08 | 0.00 | -0.13% |
| Q1 2020 Q2Q % growth | -0.10 33.33% | -0.14 | 0.04 | 27.38% |
| Q4 2019 Q2Q % growth | -0.12 | -0.17 | 0.05 | 28.26% |
| Q3 2019 Q2Q % growth | -0.21 | -0.14 | -0.07 | -53.64% |
| Q2 2019 Q2Q % growth | -0.11 | -0.15 | 0.04 | 25.11% |
| Q1 2019 Q2Q % growth | -0.15 | -0.18 | 0.03 | 18.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 9.617M -2.81% | 9.419M | 198K | 2.10% |
| Q1 2025 Q2Q % growth | 8.727M -10.82% | 9.187M | -460K | -5.01% |
| Q4 2024 Q2Q % growth | 9.15M 5.56% | 10.302M | -1.152M | -11.18% |
| Q3 2024 Q2Q % growth | 9.39M 6.58% | 10.385M | -994.61K | -9.58% |
| Q2 2024 Q2Q % growth | 9.895M 5.03% | 9.871M | 23.64K | 0.24% |
| Q1 2024 Q2Q % growth | 9.786M 3.56% | 9.98M | -193.71K | -1.94% |
| Q4 2023 Q2Q % growth | 8.668M -7.69% | 9.471M | -803K | -8.48% |
| Q3 2023 Q2Q % growth | 8.811M 8.64% | 9.461M | -650K | -6.87% |
| Q2 2023 Q2Q % growth | 9.421M 10.83% | 11.247M | -1.826M | -16.24% |
| Q1 2023 Q2Q % growth | 9.45M 8.74% | 8.908M | 541.5K | 6.08% |
| Q4 2022 Q2Q % growth | 9.39M -12.89% | 8.899M | 491K | 5.52% |
| Q3 2022 Q2Q % growth | 8.11M -16.91% | 9.159M | -1.049M | -11.45% |
| Q2 2022 Q2Q % growth | 8.5M -29.28% | 9.767M | -1.267M | -12.97% |
| Q1 2022 Q2Q % growth | 8.69M -18.02% | 9.922M | -1.232M | -12.42% |
| Q4 2021 Q2Q % growth | 10.78M -9.87% | 10.309M | 471K | 4.57% |
| Q3 2021 Q2Q % growth | 9.76M -7.49% | 11.243M | -1.483M | -13.19% |
| Q2 2021 Q2Q % growth | 12.02M 22.78% | 12.514M | -494K | -3.95% |
| Q1 2021 Q2Q % growth | 10.6M 21.70% | 11.734M | -1.134M | -9.66% |
| Q4 2020 Q2Q % growth | 11.96M 60.97% | 11.166M | 794K | 7.11% |
| Q3 2020 Q2Q % growth | 10.55M 72.95% | 9.705M | 845K | 8.71% |
| Q2 2020 Q2Q % growth | 9.79M 57.14% | 9.781M | 9K | 0.09% |
| Q1 2020 Q2Q % growth | 8.71M 67.82% | 7.145M | 1.565M | 21.90% |
| Q4 2019 Q2Q % growth | 7.43M | 6.942M | 488K | 7.03% |
| Q3 2019 Q2Q % growth | 6.1M | 6.795M | -695K | -10.23% |
| Q2 2019 Q2Q % growth | 6.23M | 6.234M | -4K | -0.06% |
| Q1 2019 Q2Q % growth | 5.19M | 6.298M | -1.108M | -17.59% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -7.71% | 15.15% | 17.02% | 44.28% |
| Revenue | 0% | -11.77% | 0.7% | -5.72% |